Clinical factors and the role of Wnt regulators in racial disparity of metastatic colorectal cancer survival.

Shin Yin Lee, Ümit Tapan, Moshe Shashar, Jamaica Siwak, Qing Zhao, Vijaya B. Kolachalama, Jean Francis, Kevan L. Hartshorn, Vipul C. ChitaliaJournal of Clinical Oncology 2016 · DOI

Abstract

6551 Background: African American (AA) colorectal cancer (CRC) patients experience lower survival compared to Caucasian Americans (CA). Aberrant Wnt/beta catenin (bcat) signaling is the hallmark of CRC pathogenesis, yet its contribution and that of its regulators to racial disparity remains elusive. Recently, Casitas B-lineage Lymphoma (c-Cbl) was identified as a suppressor of tumorigenic bcat. A negative correlation between them supports effective regulation of bcat by c-Cbl. We examined the contribution of baseline characteristics, treatment, and Wnt regulators on survival disparity in a cohort of metastatic CRC (mCRC) patients at a safety-net hospital (SNH) with a large AA population. Methods: Patients with mCRC between 2004-2014 at the largest SNH in New England were analyzed. Histologic analysis to quantify the amounts of bcat and c-Cbl was performed using a customized, color-based customized image segmentation pipeline. Results: Among 147 subjects with mCRC, 41.5% were AA, and 35.4% CA. Median survival from diagnosis was significantly lower in AA compared to non-AA (20.16 vs 25.68 months, p < 0.05). No significant differences were detected in: age, gender, Charlson Comorbidity index, tumor location, number of metastatic sites, tumor mutations (KRAS/BRAF/MSI), chemotherapy regimen, or use of biologics. There were no significant differences in number of cycles received, response rate, progression rate, or toxicity with 1st line chemotherapy. Although a negative correlation between bcat and c-Cbl was observed in AA, it was stronger in non-AA patients (Pearson correlation coefficient -0.81, 95% CI -0.93 to -0.55 for AA, and -0.87, 95% CI -0.93 to -0.77 for non-AA). Conclusions: Lower survival rates in AA mCRC patients could not simply be accounted by socioeconomic, clinical, mutation, or therapy-related parameters, thus raising the possibility of pathogenic mediators as potential contributors to the racial disparity. These data support a trend towards stronger negative correlation suggesting better control of bcat in non-AA patients. These hypothesis-generating observations may potentially explain lower survival in AA mCRC patients, although validation in a larger cohort is warranted.
BibTeX
@article{lee2016clinical,
  author = {Shin Yin Lee and Ümit Tapan and Moshe Shashar and Jamaica Siwak and Qing Zhao and Vijaya B. Kolachalama and Jean Francis and Kevan L. Hartshorn and Vipul C. Chitalia},
  title = {{Clinical factors and the role of Wnt regulators in racial disparity of metastatic colorectal cancer survival.}},
  journal = {Journal of Clinical Oncology},
  year = {2016},
  doi = {10.1200/jco.2016.34.15\_suppl.6551},
}

Loading related content...

Figure